Born in Munich, he first studied economics and graduated in business administration at the Ludwig-Maximilians-University in 1995. As he was involved with the stock market at a very early stage, he now has more than 30 years of experience in the capital markets. In the historic dot.com year 2000, he trained as a CEFA analyst in Frankfurt and has since then accompanied over 20 IPOs in Germany.
Until 2018, he held various positions at banks as an asset manager, capital market and macro expert as well as fundamental equity analyst. He is passionate about the energy, commodity and technology markets as well as the tactical and strategic asset allocation of liquid investment products. As an expert speaker at investment committee meetings of funds as well as at customer events, he can still describe the course of the 1987 crash, one of the major buying opportunities of the last 33 years on the stock market.
Today, he knows that the profit in shares is not necessarily the result of buying cheaply, but above all of avoiding mistakes and recognizing in good time when markets are ready to let air out. After all, in addition to basic fundamental analysis, investing in stocks is above all a phenomenon of global liquidity and this must be monitored regularly.
Commented by André Will-Laudien
Commented by André Will-Laudien on May 22nd, 2025 | 07:20 CEST
Caution! Takeover imminent at Evotec or BioNxt, tension remains high at Bayer and Valneva
In advanced stock market cycles, many investors wonder where returns can still be made. Defense and high tech have raced ahead, and a sector rotation remains, particularly in favor of biotech. Despite substantial gains in major indices such as the DAX 40, up nearly 20%, the Nasdaq Biotech Index (NBI) is still down nearly 7%. The excitement is mounting, as some stocks are heading north and delivering better-than-expected figures. From an analytical perspective, Evotec and BioNxt are so undervalued that a takeover can no longer be ruled out. Bayer has issued a strong statement to the US courts, and Valneva is set to outperform its previous year's Q1 figures significantly. Time for an update: Where are the buying opportunities?
Read
Commented by André Will-Laudien on May 20th, 2025 | 07:10 CEST
Where will the biotech winner of 2025 come from? Evotec, Bayer, BioNTech, Vidac Pharma, and Pfizer under stock review
With new announcements coming out of Washington daily, the stock market carousel is spinning faster and faster. The direction is no longer uniformly upward, but deeper corrections, such as those seen in April, offer good entry opportunities. While the DAX 40 index reached a new all-time high yesterday at 23,977 points and has already recorded 27% growth in 2025, the Nasdaq Biotech Index (NBI) has lost a full 7.2% over the past six months. We have examined several interesting sector players and identified both opportunities and risks. In short, careful selection is once again key!
Read
Commented by André Will-Laudien on May 19th, 2025 | 07:15 CEST
Volatus Aerospace – The next era of security technologies begins now
Geopolitical conflicts, overarching security requirements, and empty budgets pose a significant challenge for governments and administrations today. This is because highly sensitive and critical infrastructures have been created in recent decades, requiring significant public investment. These now need to be protected and maintained. In the digital age, these decision-making processes require a wealth of data that must be collected and evaluated regularly. Artificial intelligence accelerates these processes, and this is where the big game changer lies for many service providers. Volatus Aerospace (TSX-V: FLT; WKN: A2JEQU; ISIN: CA92865M1023; EUR 0.09) is a highly specialized service provider in the field of airborne inspection, surveillance, and data analysis. Business is set to take off in the current quarter as the demand for critical information increases daily. There is still time to get on board.
Read
Commented by André Will-Laudien on May 15th, 2025 | 07:15 CEST
100% buying frenzy at Palantir, investors look to D-Wave, European Lithium, and SMCI
First the sell-off, then a new high for the year. Investors can speculate about which of the recent erratic movements was the "right" one. A 20% correction in response to unresolved tariff claims was followed by a 30% rally to new highs of over 23,900 points on the DAX 40 index. The NASDAQ saw an even sharper correction, with tech stock Palantir halving in value before doubling again within four weeks. In between, Q1 figures were released that, in truth, merely met expectations. SMCI and D-Wave Quantum are now back in the spotlight due to their high beta. For those focusing on Greenland and strategic metals, European Lithium is worth a closer look. We help with the analysis.
Read
Commented by André Will-Laudien on May 13th, 2025 | 07:20 CEST
Defense out - Time to buy commodities! Hensoldt, Globex Mining, Barrick, Mutares, and Steyr
That is how quickly market darlings can fall out of favor. Just last week, Rheinmetall & Co. were hitting record highs, but as of Monday, the euphoria came to a sudden halt. Trump agreed with China on lower tariffs, and Volodymyr Zelenskyy will travel to Turkey on Thursday to sit down with Russia's aggressor, Vladimir Putin. At the moment, this is still hard to believe. For the capital markets, however, this means a shift: out of defense and into high-tech and automotive stocks, the biggest winners of recent hours. The whole thing could be seen as a healthy rotation, as the major indices are at record levels, while tech and automotive stocks have corrected significantly in recent weeks. Once again, the cards are being reshuffled. For Globex Mining, the setback is suitable for medium-term follow-up purchases.
Read
Commented by André Will-Laudien on May 12th, 2025 | 07:10 CEST
Is RENK riding the next wave? Heidelberg Materials and Argo Living are at the forefront of sustainability!
Russia's war of aggression against Ukraine and the recent tensions in transatlantic relations have triggered a profound change in the financial sector. Today, Fund managers ask themselves which criteria can be used as "ESG-compliant" or "sustainable" in this new era. The industry remains divided when it comes to defense companies. Nevertheless, fund managers are almost forced to invest in defense in order not to miss out on the steep return trend in 2025. Investors find themselves caught between expected returns and the desire for peace and stability. For RENK shares, this dilemma has given rise to dream returns that, in our view, are not yet reflected in the current figures. Heidelberg Materials and Argo Living, on the other hand, are focusing on sustainable products and have delivered impressive balance sheets so far. Investors should proceed selectively.
Read
Commented by André Will-Laudien on May 8th, 2025 | 07:10 CEST
Almonty Industries – The next 100% opportunity with strategic metals
Things continue to go well for Almonty Industries (TSX: AII; WKN: A1JSSD; ISIN: CA0203981034; EUR 1.59). The stock is already one of the best commodity stocks for 2025. The market is gradually realizing that this story could be worth billions. The trade dispute between the US and many nations is proving to be a death blow for Western industries, especially those in China. In response to announced trade tariffs of over 100%, the leadership in Beijing has imposed export restrictions on strategic metals. Tungsten is one of the most critical metals, essential for high-tech and defense applications. Deposits and producers are few and far between, with a good 70% of supply coming from China. Almonty Industries is set to start production in South Korea in 2025, and US producers are already securing valuable tungsten. A jump in valuation is on the cards!
Read
Commented by André Will-Laudien on May 7th, 2025 | 09:55 CEST
High-grade discovery at Tocvan Ventures – Gold corridor within reach at Gran Pilar
Volatility on the capital markets reached record levels in the first quarter of 2025. Geopolitical upheavals and unpredictable US policy have caused stock prices to fluctuate wildly. Precious metal investments could provide a good hedge against turbulence in the financial system and a devaluation of the US dollar. With spot prices recently reaching new record highs, investors are increasingly strengthening their exposure to the commodities sector. Gold has so far met expectations with prices of up to USD 3,500 and an annual gain of just under 20% in 2025, while silver has also reached high prices of over USD 35. In addition to producers, the spotlight is now shifting to the second tier of explorers. This is because the valuations of in-ground resources are at their lowest level in decades. Canadian gold explorer Tocvan Ventures (CSE: TOC | WKN: A2PE64 | ISIN: CA88900N1050 | CAD 0.69) has recently seen a string of positive announcements. The latest update on recent drilling at the Pilar gold-silver project in Sonora delivered impressive gold and silver grades.
Read
Commented by André Will-Laudien on May 5th, 2025 | 07:20 CEST
Biotech is back with artificial intelligence! Evotec, NetraMark Holdings, Bayer, and BioNTech
Artificial intelligence has arrived in health research! Whenever large volumes of data need to be analyzed, patterns recognized, or results condensed, immense computing power is required. The goal is to detect complex structures, automate processes, and make real-time decisions. The use of AI in medicine and pharmaceutical development is making good progress because time and high validation capability are key here. Some companies have already recognized the signs of the times and are working hard on the new technologies. On the stock market, this is often the starting signal for significantly higher valuations. Evotec, Bayer, and BioNTech are well-known European players, while Canadian company NetraMark Holdings has seen its share price increase sevenfold since fall 2024. What is behind this surge?
Read
Commented by André Will-Laudien on April 30th, 2025 | 07:10 CEST
Here we go! Plug Power turns, rollout at dynaCERT, opportunities with Mutares, VW, and BYD?
Some say the volatility is unbearable, while traders shout: opportunities everywhere. The stock market is currently relentless. Those positioned poorly can quickly see double-digit losses, but on the upside, profits are once again within reach. The former high-tech favorites are taking off again. After a spectacular sell-off at Plug Power in April, there have been strong buybacks in recent days. dynaCERT is also going full steam ahead in sales. Mutares recently delivered rather disappointing figures, and BYD could become the world's most successful automotive company in 2025. We take a closer look.
Read